Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine advanced pancreatic cancer


Yavuz A., Aydin F., Yavuz M., Ilis E., Ozdemir F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.51, ss.974-981, 2001 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 51 Konu: 4
  • Basım Tarihi: 2001
  • Doi Numarası: 10.1016/s0360-3016(01)01737-0
  • Dergi Adı: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
  • Sayfa Sayıları: ss.974-981

Özet

Purpose: To determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of twice-weekly gemcitabine (TW-G) when administered in conjunction with fixed dose amifostine (A) during external radiotherapy (RT) in patients with advanced pancreatic cancer.